Tagged with Nxera Pharma

Japan: Teva Divests Takeda Joint Venture; Astellas Opens New Cell Therapy Site

Japan Japan: Teva Divests Takeda Joint Venture; Astellas Opens New Cell Therapy Site

Japan A summary of some of the biggest stories coming out of Japan’s pharma industry, including Teva’s divestment of joint venture Teva-Takeda; GE HealthCare’s takeover of Nihon Medi-Physics; Takeda’s blood cancer anemia drug licensing deal with Keros, and Astellas’ new cell therapy research site in Japan. Pharma firm Teva to…

South Korea Pharma News: Merck Builds New $326 Million Plant; EuBiologics Gets Cholera Vaccine Prequalification

Korea South Korea Pharma News: Merck Builds New $326 Million Plant; EuBiologics Gets Cholera Vaccine Prequalification

Korea A roundup of some of the biggest stories from South Korean healthcare and pharma, including the government’s continuing standoff with doctors over medical reform plans; Merck’s plans for a new 300-million-euro plant; EuBiologics’s World Health Organization (WHO) prequalification for its cholera vaccine, and Samsung Biologics’ record Q1 earnings. South…